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Abstract
Shrimp is the fourth most important aquaculture commodity in the Philippines in terms of production 
quantity and second in terms of export value. The two species of shrimp being cultivated in the 
Philippines are the black tiger shrimp (Penaeus monodon) and Pacific white shrimp (P. vannamei). 
Although shrimp production markedly declined in the 1990’s due to luminescent vibriosis and 
white spot disease caused by Vibrio harveyi and white spot syndrome virus (WSSV), respectively, 
the industry was able to recover due to collaborative and participatory efforts of both the public 
and private sectors. Recovery programs focused on improving culture technologies, prevention 
and control of disease introduction and outbreaks and environmental enhancement. However, 
serious outbreaks of an emerging transboundary disease named acute hepatopancreatic necrosis 
disease (AHPND) caused by unique strains of V. parahaemolyticus have recently caused heavy 
economic losses among shrimps growers in some major shrimp producing provinces in the country, 
thereby threatening production growth and export expansion of the Philippine shrimp industry. 
This paper presents the status of AHPND in cultured penaeids and activities of the National Shrimp 
Health Management Program (NSHMP) of the Bureau of Fisheries and Aquatic Resources (BFAR) 
on importation policies, disease surveillance, monitoring and reporting, disease diagnosis, and 
preventive and control measures against AHPND and other transboundary diseases of cultured 
penaeids in the Philippines. 
Introduction 
Shrimp mortalities among cultured Pacific 
white shrimp (Penaeus vannamei) and 
black tiger shrimp (P. monodon) due to 
acute hepatopancreatic necrosis disease 
(AHPND) caused by unique strains of Vibrio 
parahaemolyticus (VPAHPND) have recently 
stirred great concerns among growers, hatchery 
operators, traders, exporters, importers, 
government agencies, and researchers in the 
Philippines (Dabu et al., 2015; dela Peña et al., 
2015). Amidst the economic losses experienced 
by the major shrimp-producing farms in the 
country, the Philippine Bureau of Fisheries 
and Aquatic Resources (BFAR) through its 
National Shrimp Health Management Program 
(NSHMP) has intensified its commitment 
to the shrimp industry in coming up with 
practical and effective strategies, i.e. exclusion 
and containment, aimed at controlling and 
preventing the further spread of AHPND and 
other emerging transboundary diseases of 
penaeid shrimps in the country (BFAR, 2015).
The exclusion strategy of the program includes 
the issuance of policies against AHPND, strict 
implementation on importation regulations 
of specific-pathogen-free (SPF) P. vannamei 
and P. monodon broodstocks and postlarvae 
(PL) to prevent entry of the shrimp pathogens, 
and accreditation/certification and registration 
of shrimp hatcheries and grow-out farms 
in compliance with biosecurity and health 
status monitoring of farmed shrimps. On 
the other hand, the containment strategy 
includes: (a) disease detection and diagnostic; 
(b) surveillance and reporting; (c) health 
certification for in-country transboundary 
movement of live (all stages) shrimps; (d) 
institutionalization of the sectors involved in 
the shrimp industry, especially the extensive 
farms; (e) promotion of biosecurity practices; (f) 
capacity building; and (g) massive information 
education campaign (IEC) and participation in 
training  programs and proficiency testing.
The NSHMP has been in place prior to the 
occurrence of AHPND in the country. It is a 
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regular and continuing program of BFAR that 
was officially launched in 1998 and formally 
introduced to the industry in 2000. It was 
well supported by the private sector  and other 
associated government agencies.  It aims to 
increase and expand production and exports 
through intensification of shrimp health 
management. It adheres to the principles of the 
two-pronged approaches, i.e. exclusion and 
containment. Prior to the occurrence of AHPND 
in the country, shrimp diseases included in 
the program were white spot disease (WSD), 
Taura syndrome (TS), yellowhead disease 
(YHD)/gill-associated disease (GAD), infectious 
hypodermal haematopoietic necrosis (IHHN), 
infectious myonecrosis (IMN), white tail 
disease (MrNv), necrotising hepatopancreatitis 
(NHP), P. vannamei nodavirus (PvNV) infection, 
monodon baculovirus (MBV), and luminescent 
vibriosis.
The inclusion of AHPND in the NSHMP started 
in December 2013 when shrimp productions 
were rapidly declining in neighboring countries 
due to serious outbreaks of AHPND. BFAR 
organized a meeting with the private sector 
and agreed to suspend the processing and 
approval of permit to import live shrimps 
from neighboring countries with confirmed 
cases of AHPND and infectious myonecrosis 
(IMN). Following the suspension, BFAR 
continued to encourage hatcheries to apply for 
accreditation/certification and registration for 
proper monitoring and surveillance of AHPND 
and other shrimp diseases.
History of AHPND occurrence and its 
prevalence
The first record of AHPND in the Philippines 
was documented among Pacific white shrimp 
(P. vannamei) and black tiger shrimp (P. 
monodon) obtained from selected sites in 
Luzon (Bulacan, Pampanga, Bataan, and 
Batangas provinces), Visayas (Cebu and Bohol 
provinces), and Mindanao (General Santos 
and Saranggani provinces) islands. The 
occurrence of the disease was determined by 
microbiological methods and polymerase chain 
reaction (PCR) and was further confirmed 
by histopathology of the hepatopancreas of 
infected shrimp (Dabu et al., 2015). AHPND-
infected shrimp exhibited an empty midgut 
and stomach with pale hepatopancreas (Dabu 
et al., 2015; Tran et al., 2013). Compared 
to shrimps with normal hepatopancreas, 
infected shrimps have necrotic symptoms in 
their hepatopancreas. Some infected shrimp 
samples manifested acute phase of infection 
as evidenced by loosening and minimal 
degradation of the tubule epithelial cells. In 
addition, some shrimp samples examined 
demonstrated signs of increased sloughing 
around the tubule area leading to greater spaces 
around it whereas, others have enlargement 
of the nuclei and formation of bacterial 
colonies in hepatopancreas tubule epithelial 
cells denoting an early terminal and terminal 
phases of AHPND, respectively. The prevalence 
of VPAHPND were 35% (39 positive/113 samples 
examined) in Luzon, 21% (40/194) in Visayas, 
and 5% (3/60) in Mindanao (Dabu et al., 2015). 
The presence of AHPND in the Philippines 
was also confirmed among pond-cultivated 
P. monodon and P. vannamei sampled from a 
farm in Bohol in early 2015 and late 2014 by 
another group of researchers (dela Peña et al., 
2015). Interestingly, unlike classical AHPND in 
which typical disease signs and concomitant 
mortalities occur among PLs within 20 to 30 
days after stocking in ponds, these authors 
noted that disease signs and mortality could 
still occur during the later stage of the culture 
cycle, i.e. between 46 and 96 days after pond 
stocking, suggesting that even older shrimp life 
stages are apparently susceptible to AHPND 
(dela Peña et al., 2015). 
BFAR laboratories and BFAR-recognized 
laboratories conducted a total of 2,606 
analyses for AHPND in shrimps for the year 
2015 (Table 1). AHPND positive samples totaled 
to 98, constituting 3.8 % of the total samples 
analyzed. Positive samples originated from 
14 provinces namely Pangasinan, Cagayan, 
Bulacan, Batangas, Negros Occidental, Bohol, 
Zambales, Pampanga, Cebu, Iloilo, Leyte, 
Oriental Mindoro, Marinduque and Davao del 
Sur.
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Table 1.  AHPND analysis conducted by the Bureau of Fisheries and Aquatic Resources (BFAR) Laboratories and BFAR-
recognized Laboratories in 2015.
Laboratory Method of analyses
No. of positive/Total no. 
of samples analyzed (%)
Origin of positive 
samples (province)
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Penaeus vannamei & P. 
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postlarvae
P. vannamei juvenile, water
P. vannamei & P. monodon 
juveniles, water, broodstock
P. vannamei postlarvae, 
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P. vannamei postlarvae, 
juvenile, broodstock, water
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IQPlus Toxin 1 0/25 (0)            - P. vannamei & P. monodon 
postlarvae, juveniles; 
polychaetes
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Diagnostic methods
BFAR Laboratories located in major shrimp-
producing regions have the capability to 
diagnose AHPND by molecular methods 
including IQ2000 AHPND/EMS Toxin 1 
Detection and Prevention System, IQPlus 
Toxin 1, and IQ Plus Pockit micro PCR. There 
are 17 shrimp disease diagnostic laboratories 
operating nationwide (Figure 1). Fifteen of these 
laboratories are being operated by BFAR while 
the other 2 BFAR-recognized laboratories are 
being operated by the Aquaculture Department 
of the Southeast Asian Fisheries Development 
Center (SEAFDEC/AQD) and the Negros Prawn 
Producers Cooperative (NPPC), respectively. 
Disease prevention and control
The strategies of the National Shrimp Health 
Management Program against AHPND include 
the exclusion and containment.
Exclusion strategy
This strategy involves the prevention of 
entry and spread of shrimp disease vectors 
into the country, including AHPND and other 
transboundary diseases. Because live shrimps 
(PL or broodstocks), annelids (polychaetes) 
and clams are potential carriers of pathogens, 
policies on their importation have been strictly 
practiced.  The existing policies to prevent the 
entry and spread of shrimp disease vectors have 
been approved years before the occurrence of 
AHPND in the country. These policies include 
(a) Fisheries Administrative Order (FAO) 189 
s. 1993 which prohibits the importation of live 
shrimps of all stages. This was later amended 
to include prohibition of culture of imported 
shrimps through FAO 207 s. 2001; (b) Republic 
Act 8550 of 1998 as amended by RA 10654 in 
2015 known as the Philippine Fisheries Code; 
Section 61.d on importation and exportation of 
fishery products, i.e. No person, shall import 
and/or export fishery products of whatever size, 
stage or form for any purpose without securing 
a permit from the Department; (c) FAO 207 s. of 
2001 prohibiting the importation and culture 
of imported live shrimp of all stages; and (d) 
FAO 221 s. of 2003 further regulating the 
importation of live fish and fishery or aquatic 
products under FAO 135 s. 1981 to include 
microorganisms and biomolecules.
Laboratory Method of analyses
No. of positive/Total no. 
of samples analyzed (%)
Origin of positive 
samples (province)
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It was in 2005 when experiments on culture 
and breeding of P. vannamei were conducted at 
the BFAR facility in Dagupan City, Pangasinan 
Province (Luzon). After 2 years of successful 
experimentation, importation and subsequent 
cultivation of P. vannamei in hatcheries and 
grow-out farms in the Philippines was permitted 
by the BFAR. In 2009, FAO 230 s. of 2009 was 
issued to allow the importation of specific-
pathogen-free (SPF) P. monodon broodstock 
and PL. It should be noted however, that (a) 
FAO 225 s. of 2007 (Amending FAO 207), 
i.e. allowing the importation of P. vannamei 
broodstock and culture of the offspring and 
(b) FAO 225-1 s. of 2007 stipulating the 
guidelines for the importation of P.  vannamei, 
were among the administrative orders issued 
by BFAR to regulate the importation, breeding 
and culture of P. vannamei, and prevention of 
the introduction of transboundary diseases of 
















Figure 1.  Distribution of BFAR (     ) and BFAR-recognized 
(     ) Diagnostic Laboratories for shrimp disease 
detection in the Philippines.
In 2013, when the shrimp production in China, 
Viet Nam, Thailand and Malaysia declined as a 
consequence of AHPND outbreaks (Tran et al., 
2013; Joshi et al., 2014), Fisheries Office Order 
(FOO) 146 and Fisheries General Memorandum 
Order (FGMO) 03 were issued.  FOO 146 Series 
of 2013 strictly stipulated the suspension of 
processing and approval of applications for 
permit to import all live shrimps and other 
susceptible crustaceans from Asian countries 
and other countries affected by AHPND. On the 
other hand, FGMO 03 s. 2013 enumerated the 
guidelines on accreditation of P. vannamei and P. 
monodon hatcheries for proper monitoring and 
surveillance of cultivated shrimps for AHPND 
and other equally important shrimp diseases. 
The abovementioned rules and regulations 
were presented through public consultations, 
i.e. dialogue between the government and 
private sector representatives.
Importation of specific-pathogen-free (SPF)  
P. vannamei and  P. monodon
In order to prevent the entry of shrimp 
pathogens into the country, the requirements 
for broodstock importation of BFAR accredited 
hatchery for submission to BFAR Fisheries 
Regulatory and Quarantine Division (FRQD) 
include the following: (a) letter of intent to 
import; (b) certificate of compliance issued by 
BFAR; (c) disease history of the broodstock 
facility where the broodsotck originated from 
the time of its commercialization; and (d) two 
years disease-free status of the broodstock 
facility as certified by the competent authority 
of the country of origin, and travel details. 
Upon submission, the permit to import will be 
issued by the Director of BFAR and will be only 
valid for 10 days upon issuance.
P. vannamei importation started in 2007. Only 
few hatcheries were accredited or certified 
during that time. As the demand for P. vannamei 
culture increased, more hatcheries applied for 
accreditation/certification and the number of 
imported broodstocks consequently increased. 
Importations of SPF P. vannamei broodstocks 
by BFAR-accredited hatcheries are shown in 
Table 2. The importation of SPF P. vannamei 
broodstocks significantly increased by more 
than two folds, i.e. from 6,818 to 14,519 
individuals in 2010 and 2015, respectively. 
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There is only one BFAR Accredited SPF P. 
monodon hatchery that imported a total of 528 
P. monodon broodstocks in 2015 (Table 3). The 
increase in the importation of P. vannamei and 
P. monodon broodstocks from 2013 up to 2015 
has been attributed to the rising demand for 
better quality shrimp PL.
Accreditation and  registration of SPF  
P. vannamei and P. monodon hatcheries
The minimum biosecurity standards for 
hatchery facilities of SPF P. vannamei and P. 
monodon are stipulated in FOO 225-1 s. 2007, 
FOO 225-2 s. 2008, 230, 230-1 and 231 s. 
2009. It includes: (a) treatment of incoming 
water through filtration, water disinfection 
and sedimentation, and water conditioning; 
(b) disinfection of effluent water; (c) physical 
isolation for each section in the hatchery; 
(d) provision of aeration with controlled 
airflow in each section of the facility; and (e) 
sanitation and disinfection of workers within 
the premises. The BFAR-accredited SPF P. 
vannamei and P. monodon hatcheries totaled 
to 23 and 2, respectively in 2015. To ensure 
Table 2. Number of specific-pathogen-free (SPF) P. vannamei broodstocks imported by BFAR-accredited 
hatcheries from 2010 to 2015.
Importation Data
Year
2010 2011 2012 2013 2014 2015
No. of importation 22 20 21 33 20 25
No. of female P. vannamei 
broodstocks imported (pcs)
3,424 3,538 2,768 6,960 3,967 7,410
No. of male P. vannamei 
broodstocks imported (pcs)
3,394 3,538 2,768 6,915 3,960 7,109
Total no. of P. vannamei 
broodstocks imported (pcs)
6,818 7,076 5,536 13,875 7,927 14,519
Source: BFAR, 2015
compliance to biosecurity, frequent inspections 
of hatchery facilities have been conducted by 
BFAR officers.
BFAR-accredited and registered SPF   
P. vannamei and P. monodon grow-out farms 
To date, the total number of BFAR-accredited/
certified and registered shrimp farms is 324. This 
number corresponds to a total area of 4,820.43 
hectares of cultivation ponds.  An updated list 
of accredited/certified and registered hatcheries 
and grow-out farms is posted monthly at BFAR 
website (www.da.bfar.gov.ph) depending on 
whether there are newly accredited/certified 
hatcheries or grow-out farms. The list includes 
the name of grower or hatchery, address of the 
farm and contact number(s) of grower/hatchery 
operator or representative, and accreditation/
certification or registration number. 
Containment strategy
The principle of this strategy is to prevent the 
spread of AHPND in the country, i.e. to contain 
AHPND in affected areas and to protect the yet 
uninfected areas free of AHPND. 
Table 3. Number of specific-pathogen-free (SPF) P. monodon broodstocks imported by a BFAR-accredited 




No. of importation 1 1 2
No. of female P. monodon broodstocks (pcs) 150 250 262
No. of male P. monodon broodstocks (pcs)  125 170 266
Total no. SPF P. monodon broodstocks (pcs)  275 420 528
Source: BFAR, 2015
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Disease surveillance, monitoring, and 
reporting
BFAR has been actively involved in the Quarterly 
Aquatic Animal Disease Reporting System that 
has been adopted region-wide within Asia-Pacific 
under the joint program of United Nations-
Food and Agriculture Organization (UN-FAO), 
Network of Aquaculture Centres in Asia-Pacific 
(NACA), and the World Organization for Animal 
Health (OIE).  Laboratories conducting disease 
diagnosis are required to submit quarterly 
reports to the OIE focal point for consolidation 
and report submission to the OIE. In order to 
prevent AHPND, it was recommended that the 
hatcheries and grow-out farms  practice strict 
biosecurity measures such as  longer drying 
up of tanks or ponds prior to stocking, regular 
water quality monitoring and health status 
of shrimps, and adoption of the ‘green water’ 
technology.
Health Certification for in-country 
transboundary movement of live shrimps
The issuance of health certificate (HC) for in-
country transboundary movement of live 
shrimps is primarily based on the results of 
the BFAR-prescribed laboratory tests that are 
either conducted at BFAR or BFAR-recognized 
laboratories. This is to ensure that shrimps to 
be cultured are free from diseases.  There is 
a 3% decrease in the number of HC issued in 
2015. One thousand eight hundred fifty-eight 
and 1,800 HC were issued by BFAR in 2014 
and 2015, respectively. A decrease of 59% was 
observed in the number of PLs transported, 
i.e. from 1.68 billion in 2014 to 992 million 
in 2015. This was due to a decrease in the 
demand for PLs in 2015 (Table 4).
Way forward
AHPND is already present in the Philippines. The 
Philippines was able to curb massive outbreaks 
through the application of ‘green water’ 
technology, biosecurity, health certification 
and disease surveillance, monitoring, and 
diagnosis (Usero et al., 2015). Thus, to prepare 
the country’s shrimp industry for another 
possible inadvertent emergence of a devastating 
disease, the NSHMP of BFAR recommends 
the following: (a) promotion and strict 
implementation of  Shrimp Good Aquaculture 
Practices among hatcheries and grow-out 
farms throughout the country which should 
be harmonized among ASEAN member states 
as part of the ASEAN Economic Cooperation/
Integration; (b) issuance of health certificates 
by the competent authority of the country where 
live shrimps originate; (c) accurate  laboratory 
results with accompanying lot number or batch 
of the sample being transported to prevent 
pathogen spread within the region; (d) proper 
communication among growers particularly 
with regard to prompt reporting of any possible 
or suspected disease outbreak in their farms; 
BFAR’s confirmation of the disease outbreak 
will serve as basis for an advisory to prevent 
and control further spreading of the disease; 























No. of PL 
transported
Region 3 23 Nr 56 34,288,000 11 12,504,500 13 20,000,000
Region 6 335 Nr 190 58,250,000 119 38,270,000 67 15,196,000
Region 7 1,261 770,480,455 1,634 1,099,791,400 1,661 1,429,102,345 1,616 762,417,600
Region 11 1 300,000 53 10,385,000 39 10,225,000 22 12,625,000
Region 12a - - - - - - 50 60,500,000
Central 23 19,400,000 31 29,600,000 31 101,055,000 32 121,400,000
Total 1,643 790,180,455 1964 1,142,318,400 1,858 1,681,156,845 1,800 992,138,600
HC: health certificate; PL: postlarvae
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and (e) active participation of the private sector 
in disease surveillance and reporting of any 
disease incidence to the competent authority. 
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